Acinetobacter baumannii in the critically ill: complex infections get complicated
I Cavallo, A Oliva, R Pages, F Sivori, M Truglio… - Frontiers in …, 2023 - frontiersin.org
Acinetobacter baumannii is increasingly associated with various epidemics, representing a
serious concern due to the broad level of antimicrobial resistance and clinical …
serious concern due to the broad level of antimicrobial resistance and clinical …
Current and novel therapies for management of Acinetobacter baumannii-associated pneumonia
AMS Shein, P Hongsing, ORK Smith… - Critical reviews in …, 2024 - Taylor & Francis
Acinetobacter baumannii is a common pathogen associated with hospital-acquired
pneumonia showing increased resistance to carbapenem and colistin antibiotics nowadays …
pneumonia showing increased resistance to carbapenem and colistin antibiotics nowadays …
Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii
Acinetobacter baumannii, a predominant nosocomial pathogen, represents a grave threat to
public health due to its multiple antimicrobial resistance. Managing patients afflicted with …
public health due to its multiple antimicrobial resistance. Managing patients afflicted with …
Synergistic effects of bacteriophage cocktail and antibiotics combinations against extensively drug-resistant Acinetobacter baumannii
Background The extensively drug-resistant (XDR) strains of Acinetobacter baumannii have
become a major cause of nosocomial infections, increasing morbidity and mortality …
become a major cause of nosocomial infections, increasing morbidity and mortality …
[HTML][HTML] Drug combination of ciprofloxacin and polymyxin b for the treatment of multidrug–resistant acinetobacter baumannii infections: a drug pair limiting the …
Polymyxins are considered as last–resort antibiotics to treat infections caused by
Acinetobacter baumannii. However, there are increasing reports of resistance in A …
Acinetobacter baumannii. However, there are increasing reports of resistance in A …
Vaccination with a combination of planktonic and biofilm virulence factors confers protection against carbapenem-resistant Acinetobacter baumannii strains
Acinetobacter baumannii is a multi-drug resistant pathogen with the ability to switch between
planktonic and biofilm phenotypes. Although there is no vaccine against A. baumannii …
planktonic and biofilm phenotypes. Although there is no vaccine against A. baumannii …
Rifampicin Enhanced Carbapenem Activity with Improved Antibacterial Effects and Eradicates Established Acinetobacter baumannii Biofilms
LC Nwabor, A Chukamnerd, OF Nwabor, R Pomwised… - Pharmaceuticals, 2023 - mdpi.com
Biofilm-mediated infections are critical to public health and a leading cause of resistance
among pathogens, amounting to a prolonged hospital stay and increased mortality rate in …
among pathogens, amounting to a prolonged hospital stay and increased mortality rate in …
Optimization of an in vitro Pseudomonas aeruginosa Biofilm Model to Examine Antibiotic Pharmacodynamics at the Air-Liquid Interface
Pseudomonas aeruginosa is an important cause of lower respiratory tract infections, such as
ventilator-associated bacterial pneumonia (VABP). Using inhaled antibiotics to treat VABP …
ventilator-associated bacterial pneumonia (VABP). Using inhaled antibiotics to treat VABP …